Medi Assist Healthcare Services Limited reported a consolidated net profit of ₹276 million (₹27.6 Cr) for Q1FY27, marking a 21.9% year-on-year increase from ₹226.31 million in the prior period. Total income rose 24.9% to ₹2,470 million (₹247.0 Cr), driven by a 24.1% expansion in operating revenue to ₹2,365.19 million. The company declared that its Paramount Healthcare Services acquisition integration is at its "logical closure," signaling a transition from consolidation costs to operational leverage. Despite top-line growth, consolidated EBITDA margin contracted by 175 basis points to 20.3%, down from 22.0% in Q1FY26, as the firm balances integration expenses with new technology investments.

The Board of Directors approved the unaudited results on August 8, 2026, and filed the press release on August 9, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Standalone net profit after tax surged 64% to ₹131.52 million, significantly outpacing consolidated growth, indicating strong operational efficiency at the parent entity level. Adjusted PAT, excluding a one-time ₹3.1 Cr derivative gain from the Mayfair acquisition, grew 8.2% to ₹245 million (₹24.5 Cr).

Segment Performance and Market Share

The Group business remained the primary revenue driver, contributing 70.2% of total revenue with a 25.5% year-on-year growth to ₹166.0 Cr. Premiums managed in the Group segment grew 29.5% to ₹8,454 Cr, expanding market share by 440 basis points to 37.6%. Fraud savings in this segment jumped 46.7% to approximately ₹151 Cr. In contrast, Retail TPA revenue grew 13.1% to ₹23.4 Cr, though premiums managed declined 5.0% to ₹521 Cr as the business shifts to a hybrid model. The Government segment saw robust 35.3% revenue growth to ₹28.5 Cr, servicing approximately 31 crore members across 12 states and 4 Union Territories.

Technology Monetization and International Expansion

Technology revenues emerged as a high-growth vector, rising 55.5% year-on-year to ₹7.8 Cr and accounting for 3.3% of total revenue. Medi Assist completed its planned ~₹24.5 Cr AI platform investment over the last six quarters. The stack — including MAven IDP, MAven Guard, and MATrix — is now generally available, with seven insurers contracted for AI services, including its first gain-share model. Internationally, Medi Assist raised its stake in Mayfair We Care to 91.75%, appointing Nikhil Chopra to lead the international business. The MAven platform was deployed in Thailand effective July 1, 2026. However, international benefits administration revenue softened by 5.2% to ₹10.1 Cr due to a >20% decline in leisure travelers and a >35% drop in students going abroad.

What the Numbers Show

The divergence between standalone and consolidated profitability highlights the transitional nature of the Paramount integration. While standalone net profit grew 64%, consolidated profit grew only 22%, suggesting that subsidiary operations are currently absorbing integration costs or facing margin pressure. The EBITDA margin recovery trajectory—rising from a trough of 17.1% in Q2FY26 to 20.3% in Q1FY27—indicates that integration efficiencies are beginning to materialize, though full normalization is expected by Q2FY27 when 100% claims volume migration is targeted. The debt-free balance sheet with a free cash position of ₹245.5 Cr provides ample runway for these investments without dilution. Governance changes include Dr. Vikram Jit Singh Chhatwal transitioning to Non-Executive Chairman and Gaurav Bhatnagar joining as Chief TPA Officer.

Medi Assist Healthcare has fixed Friday, September 11, 2026, as the record date to determine shareholder eligibility for its final dividend of ₹2 per equity share for the financial year ended March 31, 2026 (FY26). The Board of Directors recommended this payout during their meeting on May 09, 2026, and it remains subject to approval by shareholders at the company’s 26th Annual General Meeting (AGM). This dividend represents a direct return on capital for investors holding shares on the record date, contingent upon regulatory compliance and shareholder approval.

The 26th AGM is scheduled for Thursday, September 24, 2026, at 10:30 AM (IST), conducted via Video Conferencing or Other Audio-Visual Means in compliance with Ministry of Corporate Affairs and SEBI circulars. Upon approval at the AGM, the dividend will be remitted within 30 days through electronic payment modes to shareholders with registered bank account details. The company emphasized that dividend payments will strictly follow SEBI Master Circular No. SEBI/ HO/ MIRSD/ POD-1/ P/ CIR/ 2024/ 37 dated May 7, 2024, which mandates electronic payments only for physical shareholders who have updated their KYC details with the Registrar & Share Transfer Agent (RTA), MUFG Intime India Private Limited.

Dividend and Taxation Details

Shareholders must ensure their Permanent Account Number (PAN) is linked with Aadhaar to avoid higher tax deduction at source (TDS). Under Section 262 of the Income Tax Act, 2025, failure to link PAN with Aadhaar renders the PAN inoperative, triggering a TDS rate of 20% under Section 397. For resident individuals with valid PANs, TDS is deducted at 10% under Section 393(1) read with Section 393(4), unless they qualify for exemption under Form 121 or receive less than ₹10,000 in total dividends during FY 2026-27.

Non-resident shareholders are subject to withholding tax at 20% plus applicable surcharge and cess under Section 393(2) of the Act, unless they provide a certificate under Section 395 for lower/nil withholding or claim benefits under Double Tax Avoidance Agreements (DTAA). To avail DTAA benefits, non-residents must submit a Tax Residency Certificate, e-filed Form 41, and self-declarations by the cut-off date.

Shareholder Compliance Requirements

The company has set September 11, 2026, as the strict cut-off for submitting all tax-related documents, including Form 121, declarations under Rule 203 of the Income Tax Rules, 2026, and DTAA eligibility proofs. Documents must be uploaded via the RTA portal; email submissions will not be accepted. Intermediaries holding shares for beneficial owners must submit declarations under Rule 203 to ensure TDS credit is given to the actual beneficial owner. Failure to provide required documents may result in TDS being deducted at the highest applicable rate, though shareholders can claim refunds via their income tax returns if eligible. The company’s Company Secretary & Compliance Officer, Rashmi B V, signed the intimation on August 11, 2026.